drugset / Trial / NCT00178971
Serotonin 1A Agonists and Cognition in Schizophrenia
Phase 3
Completed
60 enrolled
Northwestern University
National Alliance for Research on Schizophrenia and Depression · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antipsychotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication.
Timeline
- Start
- 2003-01
- Primary completion
- 2004-10
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Buspirone | Small molecule | 15 mg | — |
| Comparator | Buspirone | Small molecule | 30 mg | — |